Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization

Pancreatic cancer rapidly acquires resistance to chemotherapy resulting in its being difficult to treat. Gemcitabine is the current clinical chemotherapy strategy; however, owing to gemcitabine resistance, it is only able to prolong the life of patients with pancreatic cancer for a limited number of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Yan, Tao, Li, Hai-Ying, Wu, Jian-Song, Niu, Qiang, Duan, Wei-Hong, Han, Qing-Zeng, Ji, Wang-Ming, Zhang, Tao, Lv, Wei
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652142/
https://ncbi.nlm.nih.gov/pubmed/29098031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6836
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi